The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Colchicine for Recurrent Pericarditis (CORP): A Randomized Trial
Open accessAbstract
BACKGROUND: Recurrence is the most common complication of pericarditis, affecting 10% to 50% of patients. OBJECTIVE: To evaluate the efficacy and safety of colchicine for the secondary prevention of recurrent pericarditis. DESIGN: Prospective, randomized, double-blind, placebo-controlled multicenter trial. (ClinicalTrials.gov registration number: NCT00128414) SETTING: 4 general hospitals in urban areas of Italy. PATIENTS: 120 patients with a first recurrence of pericarditis. INTERVENTION: In addition to conventional treatment, patients were randomly assigned to receive either placebo or colchicine, 1.0 to 2.0 mg on the first day followed by a maintenance dose of 0.5 to 1.0 mg/d, for 6 months. MEASUREMENTS: The primary study end point was the recurrence rate at 18 months. Secondary end points were symptom persistence at 72 hours, remission rate at 1 week, number of recurrences, time to first recurrence, disease-related hospitalization, cardiac tamponade, and rate of constrictive pericarditis. RESULTS: At 18 months, the recurrence rate was 24% in the colchicine group and 55% in the placebo group (absolute risk reduction, 0.31 [95% CI, 0.13 to 0.46]; relative risk reduction, 0.56 [CI, 0.27 to 0.73]; number needed to treat, 3 [CI, 2 to 7]). Colchicine reduced the persistence of symptoms at 72 hours (absolute risk reduction, 0.30 [CI, 0.13 to 0.45]; relative risk reduction, 0.56 [CI, 0.27 to 0.74]) and mean number of recurrences, increased the remission rate at 1 week, and prolonged the time to subsequent recurrence. The study groups had similar rates of side effects and drug withdrawal. LIMITATION: Multiple recurrences and neoplastic or bacterial causes were excluded. CONCLUSION: Colchicine is safe and effective for secondary prevention of recurrent pericarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imazio, M., Bobbio, M., Cecchi, E., Demarie, D., Demichelis, B., Pomari, F., Moratti, M., Gaschino, G., Giammaria, M., Ghisio, A., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.542738 · Cited by 614
Self-citationImazio, M., Bobbio, M., Cecchi, E., Demarie, D., Pomari, F., Moratti, M., Ghisio, A., Belli, R., & Trinchero, R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1987 · Cited by 424
Self-citationControversial Issues in the Management of Pericardial Diseases
Imazio, M., Spodick, D. H., Brucato, A., Trinchero, R., & Adler, Y. (2010) · Circulation · doi:10.1161/circulationaha.108.844753 · Cited by 414
Self-citationCorticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation
Imazio, M., Brucato, A., Cumetti, D., Brambilla, G., Demichelis, B., Ferro, S., Maestroni, S., Cecchi, E., Belli, R., Palmieri, G., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.761064 · Cited by 273
Self-citationColchicine Treatment for Recurrent Pericarditis: A Decade of Experience
Adler, Y., Finkelstein, Y., Guindo, J., Rodriguez de la Serna, A., Shoenfeld, Y., Bayes-Genis, A., Sagie, A., Bayes de Luna, A., & Spodick, D. H. (1998) · Circulation · doi:10.1161/01.cir.97.21.2183 · Cited by 242
Self-citationColchicine for pericarditis: hype or hope?
Imazio, M., Brucato, A. L., Trinchero, R., Spodick, D. H., & Adler, Y. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn608 · Cited by 147
Self-citationMedical therapy of pericardial diseases
Imazio, M., Brucato, A. L., Mayosi, B. M., Rosa, F. G. D., Lestuzzi, C., Macor, A., Trinchero, R., Spodick, D. H., & Adler, Y. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283340b97 · Cited by 139
Self-citationLong-Term Outcomes in Difficult-to-Treat Patients With Recurrent Pericarditis
Brucato, A. L., Brambilla, G., Moreo, A. M., Alberti, A., Munforti, C., Ghirardello, A., Doria, A., Shinar, Y., Livneh, A., Adler, Y., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.086 · Cited by 131
Self-citationRecurrent pericarditis. Relief with colchicine.
Soldevila, J. G., de la Serna, A. R., Ramió, J., Diaz, M. A. D. M., Subirana, M., Ayuso, M. J. P., Cosín, J., & de Luna, A. B. (1990) · Circulation · doi:10.1161/01.cir.82.4.1117 · Cited by 117
Cited by
2015 ESC Guidelines for the diagnosis and management of pericardial diseases
Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., Brucato, A., Gueret, P., Klingel, K., Lionis, C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv318 · Cited by 2,634
Self-citationColchicine—Update on mechanisms of action and therapeutic uses
Leung, Y. Y., Yao Hui, L. L., & Kraus, V. B. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.013 · Cited by 950
Klein, A. L., Abbara, S., Agler, D. A., Appleton, C. P., Asher, C. R., Hoit, B., Hung, J., Garcia, M. J., Kronzon, I., Oh, J. K., et al. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.06.023 · Cited by 773
A Randomized Trial of Colchicine for Acute Pericarditis
Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Maggiolini, S., Beqaraj, F., Demarie, D., Forno, D., Ferro, S., Maestroni, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208536 · Cited by 611
Self-citationRao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
Metadata
- Authors
- Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Belli, R., Maestroni, S., Trinchero, R., Spodick, D. H., Adler, Y., & on behalf of the CORP (COlchicine for Recurrent Pericarditis) Investigators*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2011-10-04
- Volume
- 155
- Issue
- 7
- Pages
- 409-414
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1995437293
- Cited by
- 389
- References
- 15
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Colchicine for Recurrent Pericarditis (CORP): A Randomized Trial. https://app.cochat.ai/papers/10.7326/0003-4819-155-7-201110040-00359
- The paper
- Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Belli, R., Maestroni, S., Trinchero, R., Spodick, D. H., Adler, Y., & on behalf of the CORP (COlchicine for Recurrent Pericarditis) Investigators*. (2011). Colchicine for Recurrent Pericarditis (CORP): A Randomized Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-155-7-201110040-00359
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.